Skip to content

MiniMed® 670G MMT-1760KRecalls & reported problems

Medtronic Minimed, Inc. · KIT MMT-1760K 670G REV V3.18 EN MG · Class 3

All models of MiniMed 670G (23)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

3 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
3

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169946040), received between Oct 11, 2017 and Dec 21, 2017 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Bent” (1 report).

3 FDA recall records name this device's identifier, 3 still open.

12 other recalls cover devices cleared under the same FDA submission (P160017); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Jul 31, 2024Class IOpen, Classified

    Insulin pumps that have been dropped, bumped, or experienced physical impact may have damage to internal electrical components, which may cause reduced pump battery life. Since the defect reduces the battery life overall, it shortens the time between low battery alarms and increases the frequency with which the user must insert a new battery. Further, the defect may also deliver the low battery alarm when there is significantly less time before the battery completely runs out, from the expected up to 10-hour buffer the low alert is supposed to signal, leading to device powering down and stopping insulin delivery unexpectedly. Per the firm, a subset of pumps with the defect showed the low alert alarm was delivered ~2.5 hours before the device shut off, however, patient reports indicate the time could be even shorter. Replacing the battery will not resolve this issue and the short battery life and the truncated low battery alert lead time will continue to occur. Early battery depletion could result in power loss and insulin delivery could be interrupted, resulting in under delivery of insulin potentially leading to hyperglycemia and/or DKA.

    Z-0003-2025 · Root cause: Device Design · Recall details · FDA record ↗

  2. Sep 20, 2022Class IIOpen, Classified

    Medtronic identified a cybersecurity vulnerability in the MiniMed 600 series Insulin Pump Systems associated with the communication protocol that could allow unauthorized access to the pump system. This unauthorized access could be used to deliver too much or too little insulin through delivery of an unintended insulin bolus or because insulin delivery is slowed or stopped, which could lead to hypoglycemia or hyperglycemia. The Remote Bolus feature on insulin pumps should be turned off to prevent the unauthorized access.

    Z-0193-2023 · Root cause: Component change control · Recall details · FDA record ↗

  3. May 23, 2022Class IIOpen, Classified

    Due to battery cap deterioration, this may potentially result in an incomplete battery circuit (similar to when battery cap is not attached) and a loss of power/functionality of the insulin infusion pumps.

    Z-1355-2022 · Root cause: Device Design · Recall details · FDA record ↗

Most reported problems

Device problems

  • Bent1
  • Device Displays Incorrect Message1
  • Moisture Damage1
  • Poor Quality Image1
  • Scratched Material1

Patient problems

  • No Consequences Or Impact To Patient2
  • Hyperglycemia1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 21, 2017Moisture Damage; Device Displays Incorrect Message

    THE CUSTOMER REPORTED VIA PHONE CALL THAT THE THE INSULIN PUMP CONTINUE TO ALARM AND HAD THE SYMBOL OF THE RED ARROW POINTING TO A MANUAL. THE CUSTOMER'S BLOOD GLUCOSE WAS 135 MG/DL. THE CUSTOMER STATED THAT THE FLUID UNDER PUMP. THE CUSTOMER WAS ADVISED TO DISCONTINUE USE OF THE INSULIN PUMP AND TO REVERT TO THE BACK-UP PLAN. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7139226 ↗
  • MalfunctionNov 14, 2017Poor Quality Image; Scratched Material

    THE CUSTOMER WAS REPORTED VIA PHONE CALL THAT, THE CUSTOMER RECEIVED WITH SCRATCHED DISPLAY SCREEN AND WAS NOT ABLE TO READ THE SCREEN. THE INSULIN PUMP DROPPED AND GOT CRACKED AND SCREEN IS DIFFICULT TO READ. THE BLOOD GLUCOSE WAS UNKNOWN AT THE TIME OF THE INCIDENT. CUSTOMER ADVISED TO REPLACE AND DISCONTINUE USE OF THE PUMP AND REVERT TO BACKUP PLAN. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7028813 ↗
  • InjuryOct 11, 2017Bent

    THE CUSTOMER REPORTED VIA PHONE CALL THAT THE PATIENT HAD HIGH BLOOD GLUCOSE. THE CUSTOMER¿S BLOOD GLUCOSE LEVEL WAS 412MG/DL AT THE TIME OF THE INCIDENT. THE CUSTOMER REPORTED THAT PATIENT REPORTED HAD 3 BENT CANNULAS AND BLOOD GLUCOSE WAS 412MG/DL AND KETONES 0.2 WITH NO HYPERGLYCEMIC SYSTEMS. SHE TOOK A SHOT AFTER THE 3RD SET AND THE 4TH SET WORKED OUT FINE. THE INSULIN PUMP WILL NOT BE RETURNED FOR ANALYSIS.

    Patient problems: Hyperglycemia

    MAUDE report 6941036 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P160017. One submission often covers many models, so check the product and lot details in each record.

  • Z-2981-2026 · Jul 13, 2026 · Open, Classified
    MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;
  • Z-1742-2026 · Feb 13, 2026 · Open, Classified
    MiniMed 770G Insulin Pump (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)
  • Z-1739-2026 · Feb 13, 2026 · Open, Classified
    MiniMed 670G Insulin Pump (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782)
  • Z-1265-2025 · Jan 31, 2025 · Open, Classified
    MiniMed insulin pump, REF: 770G (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)
  • Z-1266-2025 · Jan 31, 2025 · Open, Classified
    MiniMed insulin pump, REF: 780G (MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, MMT-1896)
  • Z-1261-2025 · Jan 31, 2025 · Open, Classified
    MiniMed insulin pump, REF: 670G (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782)
  • Z-0855-2022 · Jan 27, 2022 · Open, Classified
    MiniMed 630G: MMT-1715, MMT-1754, MMT-1755; MiniMed 670G: MMT-1740, MMT-1741, MMT-1742, MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782; MiniMed 770G: MMT-1880, MMT-1881
  • Z-1771-2021 · Mar 15, 2021 · Open, Classified
    MiniMed 780G Insulin Pump: Models: PUMP MMT-1885 MM780G 6.5V BLE MMOL; PUMP MMT-1886 MM780G 6.5W BLE MG; KIT MMT-1895WW MM780G 6.5V BLE SF MMOL; KIT MMT-1896WW MM780G 6.5W BLE SF M
  • Z-0516-2021 · Apr 30, 2020 · Open, Classified
    MiniMed 670G, insulin pump, Ref/Model # MMT-1760KPK, MMT-1762KCN, MMT-1762WWK - Product Usage: indicated for continuous or periodic monitoring of glucose levels in the fluid under
  • Z-0956-2020 · Nov 21, 2019 · Open, Classified
    Medtronic MiniMed 670G System with SmartGuard, Ref #s/Model Number(s) - MMT-1741, MMT-1742, MMT-1760, MMT-1761, MMT-1762, MMT-1580, MMT-1581, MMT-1582, MMT-1780, MMT-1781, and MM
  • Z-2605-2017 · May 8, 2017 · Terminated
    MiniMed 670G Insulin Infusion Pump, Catalog No. MMT-1580, MMT-1780, MMT-1782, MMT-1760.
  • Z-2604-2017 · May 8, 2017 · Terminated
    MiniMed 640G Insulin Infusion Pump, Catalog No. MMT-1511, MMT-1711, MMT-1512, MMT-1712, MMT-1551, MMT-1751, MMT-1552, MMT-1752.

Other Artificial pancreas device system, single hormonal control devices

All Artificial pancreas device system, single hormonal control devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page